{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T04:39:28Z","timestamp":1792643968907,"version":"4.5.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1097\/igc.0000000000000045","type":"journal-article","created":{"date-parts":[[2014,1,9]],"date-time":"2014-01-09T06:04:45Z","timestamp":1389247485000},"page":"178-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Secondary Leukemia After Chemotherapy and\/or Radiotherapy for Gynecologic Neoplasia"],"prefix":"10.1016","volume":"24","author":[{"given":"Takako","family":"Shimada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Okadome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumi","family":"Shimamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0000000000000045_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/cncr.23988","article-title":"Acute leukemia as a secondary malignancy in children and adolescents","volume":"115","author":"Hijiya","year":"2009","journal-title":"Cancer."},{"key":"10.1097\/IGC.0000000000000045_bb0010","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ygyno.2011.07.097","article-title":"Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis","volume":"123","author":"Vay","year":"2011","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0000000000000045_bb0015","first-page":"435","article-title":"Therapy-related leukemia and myelodysplastic syndrome","volume":"14","author":"Kantarjian","year":"1987","journal-title":"Semin Oncol."},{"key":"10.1097\/IGC.0000000000000045_bb0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0889-8588(05)70340-3","article-title":"Therapy-related myeloid leukemia","volume":"10","author":"Thirman","year":"1996","journal-title":"Hematol Oncol Clin North Am."},{"key":"10.1097\/IGC.0000000000000045_bb0025","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood.V72.4.1333.1333","article-title":"Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine","volume":"72","author":"Larson","year":"1988","journal-title":"Blood."},{"key":"10.1097\/IGC.0000000000000045_bb0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1056\/NEJM199902043400504","article-title":"Risk of leukemia after platinum-based chemotherapy for ovarian cancer","volume":"340","author":"Travis","year":"1999","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0000000000000045_bb0035","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/1097-0142(19860815)58:4<924::AID-CNCR2820580420>3.0.CO;2-Y","article-title":"The association of specific \u201cfavorable\u201d cytogenetic abnormalities with secondary leukemia","volume":"58","author":"Kantarjian","year":"1986","journal-title":"Cancer."},{"key":"10.1097\/IGC.0000000000000045_bb0040","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.leu.2402456","article-title":"Therapy of secondary leukemia","volume":"16","author":"Rowe","year":"2002","journal-title":"Leukemia."},{"key":"10.1097\/IGC.0000000000000045_bb0045","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.leu.2401552","article-title":"Secondary acute myeloid leukemia with inv (16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy","volume":"13","author":"Seymour","year":"1999","journal-title":"Leukemia."},{"key":"10.1097\/IGC.0000000000000045_bb0050","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/10428190310001593058","article-title":"Secondary acute monocytic leukemia with a translocation t (8, 16)(p 11; p 13): case report and review of the literature","volume":"45","author":"Tasaka","year":"2004","journal-title":"Leuk Lymphoma."},{"key":"10.1097\/IGC.0000000000000045_bb0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1136\/ijgc-00009577-200602001-00038","article-title":"Secondary leukemia after treatment with paclitaxel and carboplatin in a patient with recurrent ovarian cancer","volume":"16","author":"See","year":"2006","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0000000000000045_bb0060","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1111\/j.1525-1438.2007.01185.x","article-title":"Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel- and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review","volume":"18","author":"Yeasmin","year":"2008","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0000000000000045_bb0065","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0000000000000045_bb0070","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1056\/NEJM198212023072302","article-title":"Acute nonlymphocytic leukemia after therapy with alkylating agents for ovarian cancer: a study of five randomized clinical trials","volume":"307","author":"Greene","year":"1982","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0000000000000045_bb0075","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7326\/0003-4819-103-2-195","article-title":"Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin\u2019s lymphomas. Comparison with results obtained in patients treated for Hodgkin\u2019s disease and ovarian carcinoma with other alkylating agents","volume":"103","author":"Pedersen-Bjergaard","year":"1985","journal-title":"Ann Intern Med."},{"key":"10.1097\/IGC.0000000000000045_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199001043220101","article-title":"Leukemia following chemotherapy for ovarian cancer","volume":"322","author":"Kaldor","year":"1990","journal-title":"N Engl J Med."},{"key":"10.1097\/IGC.0000000000000045_bb0085","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1200\/JCO.1998.16.5.1890","article-title":"Inversion of chromosome 16 and uncommon rearrangements of the CBFB and MYH11 genes in therapy-related acute myeloid leukemia: rate events related to DNA-topoisomerase II inhibitors?","volume":"16","author":"Dissing","year":"1998","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0000000000000045_bb0090","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1034\/j.1600-0609.2002.02715.x","article-title":"Acute megakaryocytic leukemia presenting as hypercalcemia with skeletal lytic lesions","volume":"68","author":"Muler","year":"2002","journal-title":"Eur J Haematol."},{"key":"10.1097\/IGC.0000000000000045_bb0095","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood.V93.10.3167.410k44_3167_3215","article-title":"Deconstructing a disease: RAR alpha, its fusion partners and their roles in the pathogenesis of acute promyelocytic leukemia","volume":"93","author":"Melnick","year":"1999","journal-title":"Blood."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24022424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24022424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0000000000000045","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:13:32Z","timestamp":1753233212000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24022424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1048891X24022424"],"URL":"https:\/\/doi.org\/10.1097\/igc.0000000000000045","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Secondary Leukemia After Chemotherapy and\/or Radiotherapy for Gynecologic Neoplasia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0000000000000045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 by the International Gynecologic Cancer Society and the European Society of Gynaecological Oncology.","name":"copyright","label":"Copyright"}]}}